Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / United Kingdom

TB Vaccine Technology Transfer Announced

July 2008 | Company News Alert

US-based Emergent Biosolutions has announced a joint venture with the University of Oxford for the development of a tuberculosis (TB) vaccine. The Oxford-Emergent Tuberculosis Consortium will have an exclusive licence to develop and commercialise TB vaccine candidate

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
GlaxoSmithKline To Take On Merck & Co In Rotavirus Immunisation Market

Industry / United Kingdom GlaxoSmithKline (GSK) and Merck & Co are set to go head-to-head in childhood rotavirus vaccination, after the US Centre for Diseases Control and Prevention (CDC)'s Advisory Committee on Immunization...
June 2008
California Leading The Way Against Counterfeits

Industry / United States The California State Board of Pharmacy is discussing a possible extension to the deadline set to implement a state-wide ePedigree law, enforcing the tracking of all prescription medicines. The legislation...
March 2008
California Leading The Way Against Counterfeits

Industry / United States The California State Board of Pharmacy is discussing a possible extension to the deadline set to implement a state-wide ePedigree law, enforcing the tracking of all prescription medicines. The legislation...
March 2008
Shire Acquires New River Pharmaceuticals

Companies / United Kingdom UK-based drugmaker is to purchase US-based New River Pharmaceuticals, in a deal worth US$2.6bn as it attempts to consolidate its position in the lucrative attention-deficit hyperactivity disorder (ADHD)...
February 2007
AstraZeneca Takes On MRSA

Companies / United Kingdom Anglo-Swedish drugmaker AstraZeneca is to invest US$100mn in its R&D centre in Boston, Massachussetts. The extra funding will be used primarily for research into new treatments for infections,...
January 2007


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS